National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 45133 [2010-18881]

Download as PDF Federal Register / Vol. 75, No. 147 / Monday, August 2, 2010 / Notices Vaughn. The transcript for the meeting will be available on the SAMHSA Committee Web site within three weeks after the meeting. Committee Name: SAMHSA National Advisory Council. Date/Time/Type: Tuesday, August 17, 2010, from 8:30 a.m. to 5 p.m.: Open. Wednesday, August 18, 2010, from 9 a.m. to 12 noon: Open. Place: The Omni Hotel at CNN Center, 100 CNN Center, Atlanta, Georgia 30303. Contact: Toian Vaughn, M.S.W., Designated Federal Official, SAMHSA National Advisory Council and SAMHSA Committee Management Officer, 1 Choke Cherry Road, Room 8– 1089, Rockville, Maryland 20857, Telephone: (240) 276–2307; FAX: (240) 276–2220 and E-mail: toian.vaughn@samhsa.hhs.gov. Dated: July 27, 2010. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health, Services Administration. Contact Person: John F. Connaughton, Ph.D, Chief, Chartered Committees Section, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892, (301) 594–7797, connaughtonj@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: July 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–18881 Filed 7–30–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4162–20–P National Institute of Environmental Health Sciences; Notice of Closed Meeting National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting erowe on DSK5CLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special, Emphasis Panel. Clinical Trial Planning Grant Review Meeting. Date: August 19, 2010. Time: 11:30 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). VerDate Mar<15>2010 15:04 Jul 30, 2010 Jkt 220001 Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: July 26, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–18878 Filed 7–30–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention BILLING CODE 4140–01–P [FR Doc. 2010–18874 Filed 7–30–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES 45133 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Oil Dispersants Toxicity. Date: August 18, 2010. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: NIH/NIEHS, Keystone Building, 530 Davis Drive, 3118, Durham, NC (Telephone Conference Call). Contact Person: Janice B. Allen, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Science, P.O. Box 12233, MD EC–30/Room 3170 B, Research Triangle Park, NC 27709, (919) 541–7556. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 75 FR 38819–38821, dated July 6, 2010) is amended to reorganize the Management Analysis and Services Office, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in their entirety the titles and functional statements for the Management Analysis and Services Office (CAJG), insert the following: Management Analysis and Services Office (CAJG). The mission of the Management Analysis and Services Office (MASO) is to support CDC through customer-centered professional services in areas that have high impact across the agency. To achieve this mission, MASO provides consultation, analysis, and coordination in the areas of business process management; delegations of authority; electronic forms management; Federal advisory committee management; information quality; internal controls and risk management; mail center services; management studies and surveys; organizations and functions; policy development; printing procurement; and records management. Office of the Director (CAJG1). (1) Manages, directs, coordinates, supports, and implements MASO activities; (2) E:\FR\FM\02AUN1.SGM 02AUN1

Agencies

[Federal Register Volume 75, Number 147 (Monday, August 2, 2010)]
[Notices]
[Page 45133]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18881]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special, Emphasis Panel. Clinical Trial Planning 
Grant Review Meeting.
    Date: August 19, 2010.
    Time: 11:30 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: John F. Connaughton, Ph.D, Chief, Chartered 
Committees Section, Review Branch, DEA, NIDDK, National Institutes 
of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892, 
(301) 594-7797, connaughtonj@extra.niddk.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: July 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-18881 Filed 7-30-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.